Member access

4-Traders Homepage  >  Shares  >  Nyse  >  Bristol-Myers Squibb Co    BMY   US1101221083

 SummaryQuotesChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nyse
10/15/2014 10/16/2014 10/17/2014 10/20/2014 10/21/2014 Date
48.96(c) 49.22(c) 50.42(c) 50.56(c) 51.95(c) Last
7 472 355 7 188 277 9 481 484 5 871 016 6 774 295 Volume
+0.08% +0.53% +2.44% +0.28% +2.75% Change
More quotes
Company
Bristol-Myers Squibb Co. is engaged in the discovery, development, licensing, manufacturing, marketing, distribution and sale of biopharmaceutical products.Its pharmaceutical products include chemically-synthesized drugs or small molecules and an increasing portion of products produced from... 
Sector
Pharmaceuticals
Calendar
10/24Earnings Release
Surperformance© rating of Bristol-Myers Squibb Co
Trading Rating : Investor Rating :
More about the company
Chart BRISTOL-MYERS SQUIBB CO
Duration : Period :
Bristol-Myers Squibb Co Technical Analysis Chart | BMY | US1101221083 | 4-Traders
Full-screen chart
Financials ($)
Sales 2014 15 582 M
EBIT 2014 3 278 M
Net income 2014 2 734 M
Finance 2014 231 M
Yield 2014 2,77%
Sales 2015 15 513 M
EBIT 2015 3 113 M
Net income 2015 2 607 M
Finance 2015 843 M
Yield 2015 2,83%
PER 2014 31,62
PER 2015 31,14
EV / Sales 2014 5,51x
EV / Sales 2015 5,50x
Capitalization 86 128 M
More Financials
Latest news on BRISTOL-MYERS SQUIBB CO
1d agoBRISTOL-MYERS SQUIBB CO : quaterly earnings release
3d agoDJMARKET SNAPSHOT : More Than 1/3 of Dow Stocks To Report This Week
5d ago Danone decides on Mead Johnson as takeover target - sources
6d ago BRISTOL MYERS SQUIBB : Pharmacyclics and Janssen Join Forces
7d ago BRISTOL MYERS SQUIBB : An Application for the Trademark "DEMVEP" Has Been Filed ..
7d ago BRISTOL MYERS SQUIBB : Trademark Application for "UZANTEV" Filed
7d ago BRISTOL MYERS SQUIBB : An Application for the Trademark "JEQUED" Has Been Filed ..
7d ago BRISTOL MYERS SQUIBB : An Application for the Trademark "OPDIVO" Has Been Filed ..
7d ago BRISTOL MYERS SQUIBB : Research Conducted at Bristol-Myers Squibb Has Updated Ou..
7d ago BRISTOL MYERS SQUIBB : Statement about Asunaprevir in the U.S.
7d ago BRISTOL MYERS SQUIBB : Statement on Sustiva efavirenz in the U.S.
7d ago BRISTOL MYERS SQUIBB : Patent Issued for Immunoconjugates, Compositions for Maki..
More news


Comments 
Advertisement
Technical analysis trends
Short TermMid-TermLong Term
TrendsNeutralNeutralNeutral
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF